Summary of Significant Accounting Policies (Tables)

12 Months Ended

Jun. 30, 2024

Summary of Significant Accounting Policies [Abstract]

Schedule of Consolidated Financial Statements

The following financial information of the Company’s consolidated VIEs (including subsidiary of VIEs) is included in the accompanying consolidated financial statements:

	June 30, 2024			June 30, 2023
ASSETS
CURRENT ASSETS
Cash	$	113,432		$	286,272
Accounts receivable, net of $57,894 and $58,021 allowance for doubtful accounts as of June 30, 2024 and 2023, respectively		-			25,444
Prepayments		8,175			107,613
Other receivables, net		156,594			36,740
Amounts due from related parties		13,898			19,219
Amounts due from intercompanies		50			-
Inventories, net		719,315			369,327
Total current assets		1,011,464			844,615
NON-CURRENT ASSETS
Operating lease right-of-use assets, net		105,614			-
Property, plant and equipment, net		24,251			48,806
Total non-current assets		129,865			48,806
TOTAL ASSETS	$	1,141,329		$	893,421
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts payable	$	488		$	16,541
Advance from customers		-			347,429
Payroll payable		67,643			16,212
Tax payable		47,215			44,416
Operating lease liability - current		67,055			-
Other payables		49,430			63,651
Amounts due to related parties		4,447,669			3,421,327
Total current liabilities		4,679,500			3,909,576
NON-CURRENT LIABILITIES
Operating lease liability - non-current		66,685			-
Total non-current liabilities		66,685			-
TOTAL LIABILITIES	$	4,746,185		$	3,909,576
SHAREHOLDERS’ DEFICIT
Total Shareholders’ Deficit		(3,604,856	)		(3,016,155	)
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT	$	1,141,329		$	893,421

Schedule of Consolidated Income Statement

	For the years ended June 30,
	2024			2023
REVENUES	$	134,531		$	463,076
COST OF REVENUES		129,725			371,455
GROSS PROFIT		4,806			91,621
OPERATING EXPENSES
Selling expenses		20,873			20,064
General and administrative expenses		587,140			1,184,025
Total operating expenses		608,013			1,204,089
LOSS FROM OPERATIONS		(603,207	)		(1,112,468	)
OTHER  INCOME, NET
Other incomes		7,577			21,104
Other expenses		(1,775	)		(4,914	)
Total other income, net		5,802			16,190
NET LOSS BEFORE INCOME TAX		(597,405	)		(1,096,278	)
Income tax (expense) benefit		(987	)		391
NET LOSS		(598,392	)		(1,095,887	)
Other comprehensive income:
Foreign currency translation income		9,691			253,749
Total comprehensive loss	$	(588,701	)	$	(842,138	)

Schedule of Consolidated Cash Flow Statement

	For the years ended June 30,
	2024			2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(598,392	)	$	(1,095,887	)
Adjustments to reconcile net loss to net cash used in operating activities:
Allowance of doubtful accounts		9,689			638,489
Depreciation		23,502			34,663
Impairment		11,323			-
Loss on disposal of property and equipment		1,774
Operating lease right-of-use assets amortization		28,291			-
Changes in operating assets and liabilities:
Accounts receivable		25,537			(26,533	)
Other receivables		(126,175	)		1,224,585
Prepayments		99,785			(10,855	)
Inventories		(354,467	)		(91,257	)
Accounts payable		(9,329	)		(62,101	)
Advance from customers		142,232			(6,062,321	)
Payroll payable		51,768			(4,719	)
Tax payable		2,711			35,334
Other payables		(14,215	)		(4,150,362	)
Net cash used in operating activities		(705,966	)		(9,570,964	)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment		(16,977	)		(1,175	)
Cash used in investing activities		(16,977	)		(1,175	)
CASH FLOWS FROM FINANCIING ACTIVITIES
Proceeds from related parties		550,117			9,674,141
Cash provided by financing activities		550,117			9,674,141
EFFECT OF EXCHANGE RATE ON CASH		(14	)		(19,734	)
NET CHANGE IN CASH		(172,840	)		82,268
CASH AT BEGINNING OF PERIOD		286,272			204,004
CASH AT END OF PERIOD	$	113,432		$	286,272

Schedule of Depreciation is Computed Using the Straight-Line Method Over the Estimated Useful Lives of the Assets

Depreciation is computed using the straight-line method over the estimated useful lives of the assets.

	Useful Lives
Categories	(Years)
Furniture and equipment	3
Machinery	5
Motor vehicles	3

Schedule of Revenue Streams

There are two revenue streams within the Company’s operations: (1) sales of health products which constitutes the majority of the revenues, and (2) others.

	For the Years Ended
	2024		2023
	Sales		Sales
Health product sales	$	134,531	$	461,302
Others		-		1,774
Total revenues	$	134,531	$	463,076

Schedule of Exchange Rates

Translation of amounts from RMB into U.S. dollars has been made at the following exchange rates:

Balance sheet items, except for equity accounts
June 30, 2023	RMB7.2513 to $1
June 30, 2024	RMB7.2672 to $1
Income statement and cash flows items
For the years ended June 30, 2023	RMB6.9536 to $1
For the years ended June 30, 2024	RMB7.2248 to $1